Tier 4 — mechanistic

Insulin resistance and glycine metabolism in humans

Adeva-Andany M, Souto-Adeva G, Ameneiros-Rodríguez E, Fernández-Fernández C, Donapetry-García C, Domínguez-Montero A
Amino acids 2018 50(1):11-27

Bibliography

PubMed
PMID 29094215
Funding
Funding was not specified in the indexed abstract; the full funding disclosure has not been verified.
Competing interests
The accessible abstract does not establish the authors' competing interests; absence of a statement is not evidence of no conflicts.

Study snapshot

DesignNarrative review
ModelHuman and preclinical literature
SampleReview of human insulin-resistance and glycine literature
InterventionBiological and clinical interpretation of glycine metabolism
DurationNot applicable; review
EndpointsInsulin resistance; Collagen and vascular biology; Metabolic pathways

What the study showed, in plain terms

This review explores why circulating glycine is often low in insulin resistance and how it participates in other metabolic pathways. The direction of causation remains an important unresolved question.

Key findings

  • Higher glycine has been associated with more favorable metabolic profiles.
  • Glycine participates in creatine, heme, glutathione, purine and collagen metabolism.

What this study can and cannot tell us

A mechanistic narrative cannot determine whether low glycine is a cause or consequence of disease.

The review does not establish a glycine prescription for diabetes or vascular disease.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified